Hydnora Medicare Pvt Ltd
Levosulpiride (75mg) + Esomeprazole (40mg)
Esorise L 75mg/40mg Capsule is a prescription medicine used to treat gastroesophageal reflux disease (acid reflux) by relieving symptoms such as heartburn, stomach pain, or irritation.
Capsule
Esorise L 75mg/40mg Capsule is a combination of two medicines: Levosulpiride and Esomeprazole. It works by relieving the symptoms of gastroesophageal reflux disease (acid reflux) and neutralizing the acid production in the stomach to prevent discomfort.
Take this medicine in the dose and duration as advised by your doctor. Esorise L 75mg/40mg Capsule is to be taken empty stomach.
Esorise L 75mg/40mg Capsule is a combination of two medicines: Levosulpiride and Esomeprazole.
Take it one hour before the meal preferably in the morning Inform your doctor if you get watery diarrhea, fever, or stomach pain that does not go away Do not consume alcohol while taking Esorise L 75mg/40mg Capsule as it can increase the risk of stomach damage Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements. Do not take Esorise L 75mg/40mg Capsule for longer than prescribed
Store this medicine in its original container, tightly closed. Refer to the packaging or label for specific storage instructions. Do not dispose of unused medicine into regular trash or sewage systems. Keep it out of reach of children, pets, and others.
Always take Esorise L 75mg/40mg Capsule exactly as prescribed by your doctor. It is best to swallow one capsule on an empty stomach.
Use of Esorise L 75mg/40mg Capsule should be avoided in patients with known allergies to any of its components or excipients. It is important to consult your doctor if you have any questions regarding potential contraindications.
Yes, some patients taking Esorise L 75mg/40mg Capsule may experience dizziness (such as feeling faint, weak, unsteady or lightheaded). If you feel dizzy or lightheaded, it is best to rest in a quiet place until your symptoms subside.
Research indicates that treatment with Esorise L 75mg/40mg Capsule may be associated with an increased risk for osteoporosis-related fractures of the hip, wrist, or spine in some individuals. The risk of fracture was observed to be greater in patients receiving high doses and those on long-term therapy (one year or longer).